Evidence map›Paper›PMID 25972541›Full record

ArticleJournal of virology2015

Measles Virus Defective Interfering RNAs Are Generated Frequently and Early in the Absence of C Protein and Can Be Destabilized by Adenosine Deaminase Acting on RNA-1-Like Hypermutations.

Christian K Pfaller, George M Mastorakos, William E Matchett, Xiao Ma, Charles E Samuel, Roberto Cattaneo

Open access · bronzeAbstract read
In one paragraph

Article in Journal of virology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 83 papers.

0numbers the graph read from it
0cells of the map it votes in
83citing papers in PubMed
4.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

83 citing papers in PubMed, 103 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Structural insights into measles virus RNA synthesis regulation and pan-paramyxoviral polymerase inhibition by ERDRP-0519.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review

23 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Christian K PfallerDepartment of Molecular Medicine, Mayo Clinic, Rochester, Minnesota, USA.
George M MastorakosDepartment of Molecular Medicine, Mayo Clinic, Rochester, Minnesota, USA Virology and Gene Therapy Track, Mayo Graduate School, Mayo Clinic, Rochester, Minnesota, USA.
William E MatchettDepartment of Molecular Medicine, Mayo Clinic, Rochester, Minnesota, USA Virology and Gene Therapy Track, Mayo Graduate School, Mayo Clinic, Rochester, Minnesota, USA.
Xiao MaDepartment of Molecular Medicine, Mayo Clinic, Rochester, Minnesota, USA Virology and Gene Therapy Track, Mayo Graduate School, Mayo Clinic, Rochester, Minnesota, USA.
Charles E SamuelDepartment of Molecular, Cellular and Developmental Biology, University of California, Santa Barbara, California, USA.
Roberto CattaneoDepartment of Molecular Medicine, Mayo Clinic, Rochester, Minnesota, USA Virology and Gene Therapy Track, Mayo Graduate School, Mayo Clinic, Rochester, Minnesota, USA cattaneo.roberto@mayo.edu.
Mayo Clinic · USWinnMed · USUniversity of California, Santa Barbara · US

Funding

INTERFERON ACTION AND PROTEIN PHOSPHORYLATIONR01AI020611 · NIAID · UNIVERSITY OF CALIFORNIA SANTA BARBARA · PI SAMUEL, CHARLES E · 1985 to 2014
$3.4M
Immunosuppression and Innate Immunity Control by MorbillivirusesR01AI063476 · NIAID · MAYO CLINIC ROCHESTER · PI CATTANEO, ROBERTO B. · 2005 to 2014
$3.2M
MECHANISM OF INTERFERON ACTIONR01AI012520 · NIAID · UNIVERSITY OF CALIFORNIA SANTA BARBARA · PI SAMUEL, CHARLES E · 1985 to 2009
$3.1M
MECHANISM OF INTERFERON ACTIONR37AI012520 · NIAID · UNIVERSITY OF CALIFORNIA SANTA BARBARA · PI SAMUEL, CHARLES E. · 1989 to 1998
–
NIAID NIH HHS AI-12520NIAID NIH HHS AI-20611NIAID NIH HHS AI-63476NIAID NIH HHS R01 AI012520NIAID NIH HHS R01 AI020611NIAID NIH HHS R01 AI063476NIAID NIH HHS R37 AI012520
6 · The paper itself

Abstract

unlabelledDefective interfering RNAs (DI-RNAs) of the viral genome can form during infections of negative-strand RNA viruses and outgrow full-length viral genomes, thereby modulating the severity and duration of infection. Here we document the frequent de novo generation of copy-back DI-RNAs from independent rescue events both for a vaccine measles virus (vac2) and for a wild-type measles virus (IC323) as early as passage 1 after virus rescue. Moreover, vaccine and wild-type C-protein-deficient (C-protein-knockout [CKO]) measles viruses generated about 10 times more DI-RNAs than parental virus, suggesting that C enhances the processivity of the viral polymerase. We obtained the nucleotide sequences of 65 individual DI-RNAs, identified breakpoints and reinitiation sites, and predicted their structural features. Several DI-RNAs possessed clusters of A-to-G or U-to-C transitions. Sequences flanking these mutation sites were characteristic of those favored by adenosine deaminase acting on RNA-1 (ADAR1), which catalyzes in double-stranded RNA the C-6 deamination of adenosine to produce inosine, which is recognized as guanosine, a process known as A-to-I RNA editing. In individual DI-RNAs the transitions were of the same type and occurred on both sides of the breakpoint. These patterns of mutations suggest that ADAR1 edits unencapsidated DI-RNAs that form double-strand RNA structures. Encapsidated DI-RNAs were incorporated into virus particles, which reduced the infectivity of virus stocks. The CKO phenotype was dominant: DI-RNAs derived from vac2 with a CKO suppressed the replication of vac2, as shown by coinfections of interferon-incompetent lymphatic cells with viruses expressing different fluorescent reporter proteins. In contrast, coinfection with a C-protein-expressing virus did not counteract the suppressive phenotype of DI-RNAs. IMPORTANCE: Recombinant measles viruses (MVs) are in clinical trials as cancer therapeutics and as vectored vaccines for HIV-AIDS and other infectious diseases. The efficacy of MV-based vectors depends on their replication proficiency and immune activation capacity. Here we document that copy-back defective interfering RNAs (DI-RNAs) are generated by recombinant vaccine and wild-type MVs immediately after rescue. The MV C protein interferes with DI-RNA generation and may enhance the processivity of the viral polymerase. We frequently detected clusters of A-to-G or U-to-C transitions and noted that sequences flanking individual mutations contain motifs favoring recognition by the adenosine deaminase acting on RNA-1 (ADAR1). The consistent type of transitions on the DI-RNAs indicates that these are direct substrates for editing by ADAR1. The ADAR1-mediated biased hypermutation events are consistent with the protein kinase R (PKR)-ADAR1 balancing model of innate immunity activation. We show by coinfection that the C-defective phenotype is dominant.

Indexed as

MutationAdenosine DeaminaseGene Expression Regulation, ViralHumansMeaslesMeasles virusProtein StabilityRNA-Binding ProteinsRNA EditingRNA, Small InterferingRNA, ViralViral Nonstructural ProteinsADAR protein, humanAdenosine DeaminaseC protein, measles virusRNA-Binding ProteinsRNA, Small InterferingRNA, ViralViral Nonstructural Proteins

Identifiers

PMID25972541
PMCPMC4505647
OpenAlexW1566706687

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.